In a live virtual signing session, the two sides agreed to a joint venture that will see a total investment of one hundred million RMB ($15. 4 million) for the structure and launch of a world-class biogenerative medicine educational center for disease control and aesthetics. in the city of Yantai, China.
The multimillion-dollar allocation comes at a time when biological regenerative medicine has temporarily become a domain of interest, both globally and in China, amid concerns about developing fitness. region to meet existing and long-term demand.